EUVIMEDEUVIMED entdecken
Crossref

Schiff Base Mediated Synthesis of Novel Imidazolidine‐4‐One Derivatives for Potential Antimicrobial and Anthelmintic Activities

Naresh Babu Chilamakuru, Triveni Singirisetty, Anoop Bodapati, Sudha Divya Madhuri Kallam, Vinod Kumar Nelson iD, Punna Rao Suryadevara, Selvankumar Thangaswamy iD

Luminescence · 2024

DOI: 10.1002/bio.70026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Luminescence, 2024. Verfasst von Naresh Babu Chilamakuru und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Raghavendra Institute of Pharmaceutical Education and Research (RIPER) - Autonomous, Anantapur, Andhra Prades…. Hauptthemen laut MEDLINE: Microbial Sensitivity Tests, Candida albicans, Escherichia coli, Anthelmintics. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study focuses on developing novel antimicrobials to combat drug‐resistant pathogens, addressing compounds failing clinical trials due to inadequate physicochemical properties. Sixteen imidazolidine‐4‐one derivatives were synthesized by extensive evaluation using molecular docking, absorption, distribution, metabolism, excretion (ADME) predictions, and antimicrobial testing. Molecular docking studies conducted with Schrödinger's Glide revealed that compounds S4 and G8 exhibited superior docking scores of −7.839 and −7.776, respectively. The G series outperformed the S series in scores. ADME analysis confirmed all compounds adhered to Lipinski's rule of five. In addition, IR and NMR provided details about the structure of the compounds. Antimicrobial activity was assessed against Escherichia coli , Staphylococcus aureus , and Candida albicans , with compounds G2 and S2 showing exceptional minimum inhibitory concentration (MIC) values of 6.25 μg/mL against E. coli . S2 also demonstrated impressive activity against S. aureus (MIC 3.12 μg/mL), and S4 exhibited potent activity against C. albicans (MIC 0.8 μg/mL) than fluconazole (1.6 μg/mL). Additionally, antihelmintic activity was evaluated, with G1, G3, G8, S2, S4, S7, and S8 showing effective paralysis and death time 20 min and below at 50 mg/mL concentration. These results underscore the potential of new imidazolidine‐4‐one derivatives as suitable sources to develop a drug candidate to treat resistant infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Microbial Sensitivity TestsCandida albicansEscherichia coliAnthelminticsStaphylococcus aureusImidazolidinesSchiff BasesAnti-Bacterial AgentsStructure-Activity RelationshipMolecular Docking SimulationMolecular StructureAnimalsAnti-Infective Agents

Stichwörter der Autor:innen

ADMEanthelmintic activityantimicrobial activityimidazolidine‐4‐onemolecular docking

Substanzen

AnthelminticsImidazolidinesSchiff BasesAnti-Bacterial AgentsAnti-Infective Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Raghavendra Institute of Pharmaceutical Education and Research (RIPER) - Autonomous, Anantapur, Andhra Pradesh, India.
  • Department of Pharmaceutical Sciences Vignan's Foundation for Science, Technology & Research (Deemed to be University), Vadlamudi, Andhra Pradesh, India.
  • Center for Global Health Research, Saveetha Medical College, and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India.
  • Faculty of Pharmacy, Lincoln University College, Malaysia.

ORCID-Profile: Vinod Kumar Nelson, Selvankumar Thangaswamy

Zitieren

APA

Chilamakuru, N. B., Singirisetty, T., Bodapati, A., Kallam, S. D. M., Nelson, V. K., Suryadevara, P. R., & Thangaswamy, S. (2024). Schiff Base Mediated Synthesis of Novel Imidazolidine‐4‐One Derivatives for Potential Antimicrobial and Anthelmintic Activities. Luminescence. https://doi.org/10.1002/bio.70026

Vancouver

Chilamakuru NB, Singirisetty T, Bodapati A, Kallam SDM, Nelson VK, Suryadevara PR, et al. Schiff Base Mediated Synthesis of Novel Imidazolidine‐4‐One Derivatives for Potential Antimicrobial and Anthelmintic Activities. Luminescence. 2024. doi:10.1002/bio.70026

BibTeX
@article{Chilamakuru2024,
  author = {Chilamakuru, Naresh Babu and Singirisetty, Triveni and Bodapati, Anoop and Kallam, Sudha Divya Madhuri and Nelson, Vinod Kumar and Suryadevara, Punna Rao and Thangaswamy, Selvankumar},
  title = {Schiff Base Mediated Synthesis of Novel Imidazolidine‐4‐One Derivatives for Potential Antimicrobial and Anthelmintic Activities},
  journal = {Luminescence},
  year = {2024},
  doi = {10.1002/bio.70026}
}
Kostenlos starten →